87 related articles for article (PubMed ID: 27729374)
1. LPIN1 promotes epithelial cell transformation and mammary tumourigenesis via enhancing insulin receptor substrate 1 stability.
Kim JY; Kim G; Lim SC; Choi HS
Carcinogenesis; 2016 Dec; 37(12):1199-1209. PubMed ID: 27729374
[TBL] [Abstract][Full Text] [Related]
2. TAZ enhances mammary cell proliferation in 3D culture through transcriptional regulation of IRS1.
Janse van Rensburg HJ; Lai D; Azad T; Hao Y; Yang X
Cell Signal; 2018 Dec; 52():12-22. PubMed ID: 30138697
[TBL] [Abstract][Full Text] [Related]
3. Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival.
He J; Zhang F; Tay LWR; Boroda S; Nian W; Levental KR; Levental I; Harris TE; Chang JT; Du G
FASEB J; 2017 Jul; 31(7):2893-2904. PubMed ID: 28347999
[TBL] [Abstract][Full Text] [Related]
4. LPIN1 promotes triglycerides synthesis and is transcriptionally regulated by PPARG in buffalo mammary epithelial cells.
Zhou F; Fan X; Miao Y
Sci Rep; 2022 Feb; 12(1):2390. PubMed ID: 35149744
[TBL] [Abstract][Full Text] [Related]
5. miR-195 inhibits tumor growth and angiogenesis through modulating IRS1 in breast cancer.
Wang Y; Zhang X; Zou C; Kung HF; Lin MC; Dress A; Wardle F; Jiang BH; Lai L
Biomed Pharmacother; 2016 May; 80():95-101. PubMed ID: 27133044
[TBL] [Abstract][Full Text] [Related]
6. MEMO1, a new IRS1-interacting protein, induces epithelial-mesenchymal transition in mammary epithelial cells.
Sorokin AV; Chen J
Oncogene; 2013 Jun; 32(26):3130-8. PubMed ID: 22824790
[TBL] [Abstract][Full Text] [Related]
7. Insulin receptor substrate 1 knockdown in human MCF7 ER+ breast cancer cells by nuclease-resistant IRS1 siRNA conjugated to a disulfide-bridged D-peptide analogue of insulin-like growth factor 1.
Cesarone G; Edupuganti OP; Chen CP; Wickstrom E
Bioconjug Chem; 2007; 18(6):1831-40. PubMed ID: 17922544
[TBL] [Abstract][Full Text] [Related]
8. The role of insulin receptor substrate (IRS) proteins in oncogenic transformation.
Gorgisen G; Gulacar IM; Ozes ON
Cell Mol Biol (Noisy-le-grand); 2017 Jan; 63(1):1-5. PubMed ID: 28234626
[TBL] [Abstract][Full Text] [Related]
9. FGFR1 overexpression renders breast cancer cells resistant to metformin through activation of IRS1/ERK signaling.
Shi Y; Ma Z; Cheng Q; Wu Y; Parris AB; Kong L; Yang X
Biochim Biophys Acta Mol Cell Res; 2021 Jan; 1868(1):118877. PubMed ID: 33007330
[TBL] [Abstract][Full Text] [Related]
10. A novel regulation of IRS1 (insulin receptor substrate-1) expression following short term insulin administration.
Ruiz-Alcaraz AJ; Liu HK; Cuthbertson DJ; McManus EJ; Akhtar S; Lipina C; Morris AD; Petrie JR; Hundal HS; Sutherland C
Biochem J; 2005 Dec; 392(Pt 2):345-52. PubMed ID: 16128672
[TBL] [Abstract][Full Text] [Related]
11. Overexpression of ligase defective E6-associated protein, E6-AP, results in mammary tumorigenesis.
Ramamoorthy S; Tufail R; Hokayem JE; Jorda M; Zhao W; Reis Z; Nawaz Z
Breast Cancer Res Treat; 2012 Feb; 132(1):97-108. PubMed ID: 21553290
[TBL] [Abstract][Full Text] [Related]
12. Suppression of insulin receptor substrate 1 (IRS-1) promotes mammary tumor metastasis.
Ma Z; Gibson SL; Byrne MA; Zhang J; White MF; Shaw LM
Mol Cell Biol; 2006 Dec; 26(24):9338-51. PubMed ID: 17030605
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast proliferation is enhanced upon the insulin receptor substrate 1 overexpression via PI3K signaling leading to down-regulation of NFκB and BAX pathway.
Ma H; Ma JX; Xue P; Gao Y; Li YK
Exp Clin Endocrinol Diabetes; 2015 Feb; 123(2):126-31. PubMed ID: 25372512
[TBL] [Abstract][Full Text] [Related]
14. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells.
Cesarone G; Garofalo C; Abrams MT; Igoucheva O; Alexeev V; Yoon K; Surmacz E; Wickstrom E
J Cell Biochem; 2006 May; 98(2):440-50. PubMed ID: 16440325
[TBL] [Abstract][Full Text] [Related]
15. Inefficient proteasomal-degradation pathway stabilizes AP-2alpha and activates HER-2/neu gene in breast cancer.
Li M; Wang Y; Hung MC; Kannan P
Int J Cancer; 2006 Feb; 118(4):802-11. PubMed ID: 16108032
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-145 suppresses hepatocellular carcinoma by targeting IRS1 and its downstream Akt signaling.
Wang Y; Hu C; Cheng J; Chen B; Ke Q; Lv Z; Wu J; Zhou Y
Biochem Biophys Res Commun; 2014 Apr; 446(4):1255-60. PubMed ID: 24690171
[TBL] [Abstract][Full Text] [Related]
17. Downregulation of miR-145 associated with cancer progression and VEGF transcriptional activation by targeting N-RAS and IRS1.
Yin Y; Yan ZP; Lu NN; Xu Q; He J; Qian X; Yu J; Guan X; Jiang BH; Liu LZ
Biochim Biophys Acta; 2013 Feb; 1829(2):239-47. PubMed ID: 23201159
[TBL] [Abstract][Full Text] [Related]
18. Insulin receptor substrate 1 overexpression promotes survival of glioblastoma cells through AKT1 activation.
Gorgisen G; Yaren Z
Folia Neuropathol; 2020; 58(1):38-44. PubMed ID: 32337956
[TBL] [Abstract][Full Text] [Related]
19. Insulin receptor substrates 1 and 2 but not Shc can activate the insulin receptor independent of insulin and induce proliferation in CHO-IR cells.
Niessen M; Jaschinski F; Item F; McNamara MP; Spinas GA; Trüb T
Exp Cell Res; 2007 Feb; 313(4):805-15. PubMed ID: 17222824
[TBL] [Abstract][Full Text] [Related]
20. Insulin receptor substrate 1 regulates the cellular differentiation and the matrix metallopeptidase expression of preosteoblastic cells.
Bu YH; He YL; Zhou HD; Liu W; Peng D; Tang AG; Tang LL; Xie H; Huang QX; Luo XH; Liao EY
J Endocrinol; 2010 Sep; 206(3):271-7. PubMed ID: 20525764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
